Cyclophosphamide (CP)-induced lung toxicity is a remaining obstacle against the beneficial use of this chemotherapeutic agent. More considerations were given to the role of Alogliptin (ALO) in ameliorating CP-induced toxicities in many tissues. We designed this study to clarify the protective potential of ALO against CP-induced lung toxicity in rats. ALO was administered for 7 days. Single-dose CP was injected on the 2nd day (200 mg/kg: i.p.) to induce lung toxicity. Rats were divided into four groups: control, ALO-treated, CP-treated and ALO + CP-treated group. Leucocytic count, total proteins, LDH activity, TNF-α, and IL-6 were estimated in the bronchoalveolar lavage fluid (BALF). The oxidative/antioxidants (MDA, Nrf2, TAO and GSH), inflammatory (NFκB), fibrotic (TGF-β1) and apoptotic (PI3K/Akt/FoxO1) markers in pulmonary homogenates were biochemically evaluated. Rat lung sections were examined histologically (light and electron microscopic examination) and immunohistochemically (for iNOS and CD68 positive alveolar macrophages). CP significantly increased oxidative stress, inflammation, fibrosis, and apoptosis markers as well as deteriorated the histopathological pulmonary architecture. These hazardous effects were significantly ameliorated by ALO treatment. ALO protected against CP-induced lung toxicity by mitigating the oxidative, inflammatory and fibrotic impacts making it a promising pharmacological therapy for mitigating CP-induced lung toxicity. Graphical abstract
Background: Gout is a metabolic disease strictly related to hyperuricemia. The associated intense inflammation and pain are triggered by the deposited monosodium urate crystals (MSU) in joints. The principal therapeutic strategies of gout involve the control of hyperuricemia and antiinflammatory medications. Objectives: This study aimed to investigate the possible beneficial effects of ozone therapy, a wellknown antioxidant and an immunomodulator, on gouty arthritis and the underlying mechanisms. Methods : Acute gouty arthritis was induced in male albino rats via MSU crystals intra-articular injection in the ankle joint. The gouty arthritic rats received pre-treatment with ozone, colchicine (as a reference drug), or their combination. Results : The obtained results of ozone therapy showed an obvious reduction in the degree of edematous ankle swelling, pro-inflammatory cytokines, lipid peroxidation, the nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3 (NLRP3), procaspase-1, caspase-1, interleukin- 1β synovial tissue levels with an enhancement of antioxidant defense system. Additionally, ozone therapy significantly attenuated the histological derangements in gouty arthritic rats. Conclusion : This study suggests that ozone is able to treat gouty arthritis and reducing synovial injury through an anti-inflammatory effect as well as antioxidant activity.
10 July 2022 in Zagazig University Medical Journal
Background: Cisplatin is one of the most widely used anticancer drugs. As most of chemotherapeutic drugs it doesn’t only target cancerous cells but also distributed to normal cells causing many organs toxicity. Being the most important organ in the immune system; the spleen affection by cisplatin treatment must be carefully prevented or reversed. This current study aimed to assess the protective effect of a Notch inhibitor dibenzazepine (DBZ) against cisplatin induced splenic toxicity as well as exploring the proposed mechanism shedding light to the role of Notch pathway in its effect. Methods: Rats were treated with DBZ (2mg/kg) for 12 days with a single dose cisplatin (7mg/kg) injected on 8th day of treatment. rats were divided into four groups: Control, DBZ, Cisplatin and DBZ+ Cisplatin group. Results: Cisplatin injection upregulated the oxidative stress markers MDA and iNOS along with reduced antioxidant enzymes glutathione and catalase. The inflammatory markers (TNFα, IL1β and NK𝜅B) were also upregulated. Furthermore, the Notch-1 and Hes-1 expression were also significantly elevated. Cisplatin induced splenic tissue damage was further assured by light and electron microscopic histopathological examination. DBZ pre-treatment significantly restored the upregulated oxidative stress, inflammatory as well as Notch signalling pathways towards normal levels. Additionally, the histopathological architecture impairment was improved by Dibenzazepine. Conclusion: The study elucidated that DBZ protects against cisplatin-induced toxicity in rats via antioxidative and anti-inflammatory effects. Moreover, downregulating the Notch signalling pathway was proved to play a role in DBZ protective effect against cisplatin-induced splenic toxicity.